메뉴 건너뛰기




Volumn 123, Issue , 2015, Pages 193-203

Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA

Author keywords

cccDNA; Hepatitis B virus; Immunomodulators; Immunotherapy; Prime boost immunization

Indexed keywords

ANTIVIRUS AGENT; CIRCULAR DNA; COVALENTLY CLOSE CIRCULAR DNA; IMMUNOMODULATING AGENT; INTERLEUKIN 12; TOLL LIKE RECEPTOR 7 AGONIST; TOLL LIKE RECEPTOR 8 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR;

EID: 84946018523     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.10.009     Document Type: Review
Times cited : (38)

References (139)
  • 1
    • 84988814923 scopus 로고    scopus 로고
    • HDV2 O-09: REP 2139 monotherapy and combination therapy with pegylated interferon: Safety and potent reduction of HBsAg and HDV RNA in Caucasian patients with chronic HBV/HDV co-infection
    • M. Bazinet, V. Pantea, V. Cebotarescu, L. Cojuhari, P. Jimbei, and A. Vaillant HDV2 O-09: REP 2139 monotherapy and combination therapy with pegylated interferon: safety and potent reduction of HBsAg and HDV RNA in Caucasian patients with chronic HBV/HDV co-infection J. Viral Hepat. 2015 5 6
    • (2015) J. Viral Hepat. , pp. 5-6
    • Bazinet, M.1    Pantea, V.2    Cebotarescu, V.3    Cojuhari, L.4    Jimbei, P.5    Vaillant, A.6
  • 2
    • 84921332527 scopus 로고    scopus 로고
    • Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
    • B. Bengsch, B. Martin, and R. Thimme Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation J. Hepatol. 6 2014 1212 1219
    • (2014) J. Hepatol. , vol.6 , pp. 1212-1219
    • Bengsch, B.1    Martin, B.2    Thimme, R.3
  • 4
    • 84935475377 scopus 로고    scopus 로고
    • Chronic hepatitis B: A wave of new therapies on the horizon
    • T.M. Block, S. Rawat, and C.L. Brosgart Chronic hepatitis B: a wave of new therapies on the horizon Antiviral Res. 2015 69 81
    • (2015) Antiviral Res. , pp. 69-81
    • Block, T.M.1    Rawat, S.2    Brosgart, C.L.3
  • 7
    • 84861822888 scopus 로고    scopus 로고
    • Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model
    • M. Bourgine, S. Dion, O. Godon, G. Guillen, M.L. Michel, and J.C. Aguilar Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model Virology 1 2012 10 19
    • (2012) Virology , vol.1 , pp. 10-19
    • Bourgine, M.1    Dion, S.2    Godon, O.3    Guillen, G.4    Michel, M.L.5    Aguilar, J.C.6
  • 8
  • 9
    • 84891490960 scopus 로고    scopus 로고
    • B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function
    • G. Cai, X. Nie, L. Li, L. Hu, B. Wu, J. Lin, C. Jiang, H. Wang, X. Wang, and Q. Shen B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function J. Gastroenterol. 12 2013 1362 1372
    • (2013) J. Gastroenterol. , vol.12 , pp. 1362-1372
    • Cai, G.1    Nie, X.2    Li, L.3    Hu, L.4    Wu, B.5    Lin, J.6    Jiang, C.7    Wang, H.8    Wang, X.9    Shen, Q.10
  • 10
    • 84980396144 scopus 로고    scopus 로고
    • Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result
    • S. Cai, T. Yu, Y. Jiang, Y. Zhang, F. Lv, and J. Peng Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result Clin. Exp. Med. 2015
    • (2015) Clin. Exp. Med.
    • Cai, S.1    Yu, T.2    Jiang, Y.3    Zhang, Y.4    Lv, F.5    Peng, J.6
  • 11
    • 84872932013 scopus 로고    scopus 로고
    • Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure
    • D. Cao, H. Xu, G. Guo, Z. Ruan, L. Fei, Z. Xie, Y. Wu, and Y. Chen Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure Inflammation 1 2013 110 120
    • (2013) Inflammation , vol.1 , pp. 110-120
    • Cao, D.1    Xu, H.2    Guo, G.3    Ruan, Z.4    Fei, L.5    Xie, Z.6    Wu, Y.7    Chen, Y.8
  • 12
    • 79951866610 scopus 로고    scopus 로고
    • Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection
    • J.S. Cavenaugh, D. Awi, M. Mendy, A.V. Hill, H. Whittle, and S.J. McConkey Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection PLoS One 2 2011 e14626
    • (2011) PLoS One , vol.2 , pp. e14626
    • Cavenaugh, J.S.1    Awi, D.2    Mendy, M.3    Hill, A.V.4    Whittle, H.5    McConkey, S.J.6
  • 13
    • 84938368956 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure
    • J. Chang, and J.T. Guo Treatment of chronic hepatitis B with pattern recognition receptor agonists: current status and potential for a cure Antiviral Res. 2015 152 159
    • (2015) Antiviral Res. , pp. 152-159
    • Chang, J.1    Guo, J.T.2
  • 14
    • 84869118771 scopus 로고    scopus 로고
    • The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy
    • J. Chang, T.M. Block, and J.T. Guo The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy Antiviral Res. 3 2012 405 413
    • (2012) Antiviral Res. , vol.3 , pp. 405-413
    • Chang, J.1    Block, T.M.2    Guo, J.T.3
  • 15
    • 84939947684 scopus 로고    scopus 로고
    • Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection
    • J.H. Chen, C.J. Perry, Y.C. Tsui, M.M. Staron, I.A. Parish, C.X. Dominguez, D.W. Rosenberg, and S.M. Kaech Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection Nat. Med. 4 2015 327 334
    • (2015) Nat. Med. , vol.4 , pp. 327-334
    • Chen, J.H.1    Perry, C.J.2    Tsui, Y.C.3    Staron, M.M.4    Parish, I.A.5    Dominguez, C.X.6    Rosenberg, D.W.7    Kaech, S.M.8
  • 17
    • 84910623522 scopus 로고    scopus 로고
    • 2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor
    • M.H. Cho, H. Jeong, Y.S. Kim, J.W. Kim, and G. Jung 2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor J. Viral Hepat. 12 2014 843 852
    • (2014) J. Viral Hepat. , vol.12 , pp. 843-852
    • Cho, M.H.1    Jeong, H.2    Kim, Y.S.3    Kim, J.W.4    Jung, G.5
  • 19
    • 84874727114 scopus 로고    scopus 로고
    • A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice
    • M.A. Cobleigh, X. Wei, and M.D. Robek A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice J. Virol. 5 2013 2969 2973
    • (2013) J. Virol. , vol.5 , pp. 2969-2973
    • Cobleigh, M.A.1    Wei, X.2    Robek, M.D.3
  • 20
    • 84872189529 scopus 로고    scopus 로고
    • The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection
    • K.D. Cook, and J.K. Whitmire The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection J. Immunol. 2 2013 641 649
    • (2013) J. Immunol. , vol.2 , pp. 641-649
    • Cook, K.D.1    Whitmire, J.K.2
  • 21
    • 79955088827 scopus 로고    scopus 로고
    • Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: A review of HEPLISAV safety and efficacy
    • C. Cooper, and D. Mackie Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV safety and efficacy Expert Rev. Vaccines 4 2011 417 427
    • (2011) Expert Rev. Vaccines , vol.4 , pp. 417-427
    • Cooper, C.1    Mackie, D.2
  • 22
    • 42549152118 scopus 로고    scopus 로고
    • CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years
    • C.L. Cooper, J.B. Angel, I. Seguin, H.L. Davis, and D.W. Cameron CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years Clin. Infect. Dis. 8 2008 1310 1314
    • (2008) Clin. Infect. Dis. , vol.8 , pp. 1310-1314
    • Cooper, C.L.1    Angel, J.B.2    Seguin, I.3    Davis, H.L.4    Cameron, D.W.5
  • 24
    • 84892856584 scopus 로고    scopus 로고
    • Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads
    • K.K. Dietze, G. Zelinskyy, J. Liu, F. Kretzmer, S. Schimmer, and U. Dittmer Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads PLoS Pathog. 12 2013 e1003798
    • (2013) PLoS Pathog. , vol.12 , pp. e1003798
    • Dietze, K.K.1    Zelinskyy, G.2    Liu, J.3    Kretzmer, F.4    Schimmer, S.5    Dittmer, U.6
  • 25
    • 84927513847 scopus 로고    scopus 로고
    • Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
    • C. Dong, L. Qu, H. Wang, L. Wei, Y. Dong, and S. Xiong Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication Antiviral Res. 2015 110 117
    • (2015) Antiviral Res. , pp. 110-117
    • Dong, C.1    Qu, L.2    Wang, H.3    Wei, L.4    Dong, Y.5    Xiong, S.6
  • 27
    • 34548641466 scopus 로고    scopus 로고
    • The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging
    • J.J. Feld, D. Colledge, V. Sozzi, R. Edwards, M. Littlejohn, and S.A. Locarnini The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging Antiviral Res. 2 2007 168 177
    • (2007) Antiviral Res. , vol.2 , pp. 168-177
    • Feld, J.J.1    Colledge, D.2    Sozzi, V.3    Edwards, R.4    Littlejohn, M.5    Locarnini, S.A.6
  • 28
    • 77958156535 scopus 로고    scopus 로고
    • The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines
    • F. Feng, C.Q. Teoh, Q. Qiao, D. Boyle, and A.R. Jilbert The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines Vaccine 46 2010 7436 7443
    • (2010) Vaccine , vol.46 , pp. 7436-7443
    • Feng, F.1    Teoh, C.Q.2    Qiao, Q.3    Boyle, D.4    Jilbert, A.R.5
  • 30
    • 84872035154 scopus 로고    scopus 로고
    • Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B
    • S.P. Fletcher, D.J. Chin, D.T. Cheng, P. Ravindran, H. Bitter, L. Gruenbaum, P.J. Cote, H. Ma, K. Klumpp, and S. Menne Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B Hepatology 1 2013 13 22
    • (2013) Hepatology , vol.1 , pp. 13-22
    • Fletcher, S.P.1    Chin, D.J.2    Cheng, D.T.3    Ravindran, P.4    Bitter, H.5    Gruenbaum, L.6    Cote, P.J.7    Ma, H.8    Klumpp, K.9    Menne, S.10
  • 36
    • 84940195264 scopus 로고    scopus 로고
    • Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities
    • R.G. Gish, B.D. Given, C.L. Lai, S.A. Locarnini, J.Y. Lau, D.L. Lewis, and T. Schluep Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities Antiviral Res. 2015 47 58
    • (2015) Antiviral Res. , pp. 47-58
    • Gish, R.G.1    Given, B.D.2    Lai, C.L.3    Locarnini, S.A.4    Lau, J.Y.5    Lewis, D.L.6    Schluep, T.7
  • 38
    • 0033617583 scopus 로고    scopus 로고
    • Viral clearance without destruction of infected cells during acute HBV infection
    • L.G. Guidotti, R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F.V. Chisari Viral clearance without destruction of infected cells during acute HBV infection Science 284 1999 825 829
    • (1999) Science , vol.284 , pp. 825-829
    • Guidotti, L.G.1    Rochford, R.2    Chung, J.3    Shapiro, M.4    Purcell, R.5    Chisari, F.V.6
  • 39
    • 84940183673 scopus 로고    scopus 로고
    • Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics
    • J.T. Guo, and H. Guo Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics Antiviral Res. 2015 91 100
    • (2015) Antiviral Res. , pp. 91-100
    • Guo, J.T.1    Guo, H.2
  • 42
    • 84872134939 scopus 로고    scopus 로고
    • Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice
    • M. Huang, R. Sun, H. Wei, and Z. Tian Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice Hepatology 1 2013 277 288
    • (2013) Hepatology , vol.1 , pp. 277-288
    • Huang, M.1    Sun, R.2    Wei, H.3    Tian, Z.4
  • 44
    • 83455246039 scopus 로고    scopus 로고
    • Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B
    • X. Jiang, M. Zhang, Q. Lai, X. Huang, Y. Li, J. Sun, W.G. Abbott, S. Ma, and J. Hou Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B PLoS One 12 2011 e28871
    • (2011) PLoS One , vol.12 , pp. e28871
    • Jiang, X.1    Zhang, M.2    Lai, Q.3    Huang, X.4    Li, Y.5    Sun, J.6    Abbott, W.G.7    Ma, S.8    Hou, J.9
  • 46
    • 77549086947 scopus 로고    scopus 로고
    • T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
    • Y. Ju, N. Hou, J. Meng, X. Wang, X. Zhang, D. Zhao, Y. Liu, F. Zhu, L. Zhang, W. Sun, X. Liang, L. Gao, and C. Ma T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B J. Hepatol. 3 2010 322 329
    • (2010) J. Hepatol. , vol.3 , pp. 322-329
    • Ju, Y.1    Hou, N.2    Meng, J.3    Wang, X.4    Zhang, X.5    Zhao, D.6    Liu, Y.7    Zhu, F.8    Zhang, L.9    Sun, W.10    Liang, X.11    Gao, L.12    Ma, C.13
  • 47
    • 0034596944 scopus 로고    scopus 로고
    • Natural killer T cell activation inhibits hepatitis B virus replication in vivo
    • K. Kakimi, L.G. Guidotti, Y. Koezuka, and F.V. Chisari Natural killer T cell activation inhibits hepatitis B virus replication in vivo J. Exp. Med. 7 2000 921 930
    • (2000) J. Exp. Med. , vol.7 , pp. 921-930
    • Kakimi, K.1    Guidotti, L.G.2    Koezuka, Y.3    Chisari, F.V.4
  • 48
    • 84946076459 scopus 로고    scopus 로고
    • Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B
    • S.B. Kim, S.U. Kim, B.K. Kim, J.Y. Park, D.Y. Kim, S.H. Ahn, and K.H. Han Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B J. Gastroenterol. Hepatol. 2015
    • (2015) J. Gastroenterol. Hepatol.
    • Kim, S.B.1    Kim, S.U.2    Kim, B.K.3    Park, J.Y.4    Kim, D.Y.5    Ahn, S.H.6    Han, K.H.7
  • 50
    • 84866169967 scopus 로고    scopus 로고
    • DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model
    • A.D. Kosinska, L. Johrden, E. Zhang, M. Fiedler, A. Mayer, O. Wildner, M. Lu, and M. Roggendorf DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model J. Virol. 17 2012 9297 9310
    • (2012) J. Virol. , vol.17 , pp. 9297-9310
    • Kosinska, A.D.1    Johrden, L.2    Zhang, E.3    Fiedler, M.4    Mayer, A.5    Wildner, O.6    Lu, M.7    Roggendorf, M.8
  • 54
    • 84879601220 scopus 로고    scopus 로고
    • Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance
    • P. Lan, C. Zhang, Q. Han, J. Zhang, and Z. Tian Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance Hepatology 1 2013 73 85
    • (2013) Hepatology , vol.1 , pp. 73-85
    • Lan, P.1    Zhang, C.2    Han, Q.3    Zhang, J.4    Tian, Z.5
  • 57
    • 84879315928 scopus 로고    scopus 로고
    • Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice
    • F. Li, H. Wei, H. Wei, Y. Gao, L. Xu, W. Yin, R. Sun, and Z. Tian Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice Gastroenterology 2 2013 392 401
    • (2013) Gastroenterology , vol.2 , pp. 392-401
    • Li, F.1    Wei, H.2    Wei, H.3    Gao, Y.4    Xu, L.5    Yin, W.6    Sun, R.7    Tian, Z.8
  • 59
    • 84922756184 scopus 로고    scopus 로고
    • Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B
    • J. Li, M. Jia, Y. Liu, W. She, L. Li, J. Wang, and W. Jiang Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B Liver Int. 3 2015 834 845
    • (2015) Liver Int. , vol.3 , pp. 834-845
    • Li, J.1    Jia, M.2    Liu, Y.3    She, W.4    Li, L.5    Wang, J.6    Jiang, W.7
  • 60
    • 84968842075 scopus 로고    scopus 로고
    • Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: Results of a randomised trial
    • Y.S. Lim, B.C. Yoo, K.S. Byun, S.Y. Kwon, Y.J. Kim, J. An, H.C. Lee, and Y.S. Lee Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial Gut 2015
    • (2015) Gut
    • Lim, Y.S.1    Yoo, B.C.2    Byun, K.S.3    Kwon, S.Y.4    Kim, Y.J.5    An, J.6    Lee, H.C.7    Lee, Y.S.8
  • 63
    • 30344458192 scopus 로고    scopus 로고
    • Cellular and virological mechanisms of HBV drug resistance
    • S. Locarnini, and W.S. Mason Cellular and virological mechanisms of HBV drug resistance J. Hepatol. 2 2006 422 431
    • (2006) J. Hepatol. , vol.2 , pp. 422-431
    • Locarnini, S.1    Mason, W.S.2
  • 66
    • 84928888455 scopus 로고    scopus 로고
    • Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses
    • Z. Ma, E. Zhang, D. Yang, and M. Lu Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses Cell Mol. Immunol. 3 2015 273 282
    • (2015) Cell Mol. Immunol. , vol.3 , pp. 273-282
    • Ma, Z.1    Zhang, E.2    Yang, D.3    Lu, M.4
  • 67
    • 84883746075 scopus 로고    scopus 로고
    • NK cells: A double-edged sword in chronic hepatitis B virus infection
    • M.K. Maini, and D. Peppa NK cells: a double-edged sword in chronic hepatitis B virus infection Front. Immunol. 2013 57
    • (2013) Front. Immunol. , pp. 57
    • Maini, M.K.1    Peppa, D.2
  • 69
    • 81355129949 scopus 로고    scopus 로고
    • 1114 anti-viral efficacy and induction of an antibody response against surface antigen with the TLR7 agonist GS-9620 in the woodchuck model of chronic HBV infection
    • S. Menne, B.C. Tennant, K.H. Liu, M.A. Ascenzi, B.H. Baldwin, C.A. Bellezza, P.J. Cote, X. Zheng, G. Wolfgang, and D. Turnas 1114 anti-viral efficacy and induction of an antibody response against surface antigen with the TLR7 agonist GS-9620 in the woodchuck model of chronic HBV infection J. Hepatol. 2011 S441
    • (2011) J. Hepatol. , pp. S441
    • Menne, S.1    Tennant, B.C.2    Liu, K.H.3    Ascenzi, M.A.4    Baldwin, B.H.5    Bellezza, C.A.6    Cote, P.J.7    Zheng, X.8    Wolfgang, G.9    Turnas, D.10
  • 71
    • 40849083509 scopus 로고    scopus 로고
    • Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection
    • D.S. Miller, D. Boyle, F. Feng, G.Y. Reaiche, I. Kotlarski, R. Colonno, and A.R. Jilbert Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection Virology 2 2008 329 341
    • (2008) Virology , vol.2 , pp. 329-341
    • Miller, D.S.1    Boyle, D.2    Feng, F.3    Reaiche, G.Y.4    Kotlarski, I.5    Colonno, R.6    Jilbert, A.R.7
  • 72
    • 0028270410 scopus 로고
    • MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice
    • D. Moskophidis, F. Lechner, H. Hengartner, and R.M. Zinkernagel MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice J. Immunol. 10 1994 4976 4983
    • (1994) J. Immunol. , vol.10 , pp. 4976-4983
    • Moskophidis, D.1    Lechner, F.2    Hengartner, H.3    Zinkernagel, R.M.4
  • 74
    • 84885929771 scopus 로고    scopus 로고
    • Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro
    • F. Noordeen, A. Vaillant, and A.R. Jilbert Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro Antimicrob. Agents Chemother. 11 2013 5291 5298
    • (2013) Antimicrob. Agents Chemother. , vol.11 , pp. 5291-5298
    • Noordeen, F.1    Vaillant, A.2    Jilbert, A.R.3
  • 77
    • 84857358267 scopus 로고    scopus 로고
    • Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
    • J.J. Ott, G.A. Stevens, J. Groeger, and S.T. Wiersma Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 12 2012 2212 2219
    • (2012) Vaccine , vol.12 , pp. 2212-2219
    • Ott, J.J.1    Stevens, G.A.2    Groeger, J.3    Wiersma, S.T.4
  • 78
    • 0032191962 scopus 로고    scopus 로고
    • Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection
    • A. Oxenius, R.M. Zinkernagel, and H. Hengartner Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection Immunity 4 1998 449 457
    • (1998) Immunity , vol.4 , pp. 449-457
    • Oxenius, A.1    Zinkernagel, R.M.2    Hengartner, H.3
  • 86
    • 84880276248 scopus 로고    scopus 로고
    • Pathogenesis of chronic viral hepatitis: Differential roles of T cells and NK cells
    • B. Rehermann Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Nat. Med. 7 2013 859 868
    • (2013) Nat. Med. , vol.7 , pp. 859-868
    • Rehermann, B.1
  • 87
    • 0029838758 scopus 로고    scopus 로고
    • The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response
    • B. Rehermann, C. Ferrari, C. Pasquinelli, and F.V. Chisari The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response Nat. Med. 10 1996 1104 1108
    • (1996) Nat. Med. , vol.10 , pp. 1104-1108
    • Rehermann, B.1    Ferrari, C.2    Pasquinelli, C.3    Chisari, F.V.4
  • 88
    • 0030008076 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
    • B. Rehermann, D. Lau, J.H. Hoofnagle, and F.V. Chisari Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection J. Clin. Invest. 7 1996 1655 1665
    • (1996) J. Clin. Invest. , vol.7 , pp. 1655-1665
    • Rehermann, B.1    Lau, D.2    Hoofnagle, J.H.3    Chisari, F.V.4
  • 89
    • 84942163394 scopus 로고    scopus 로고
    • Virus-Like vesicle-based therapeutic vaccine vectors for chronic hepatitis B virus infection
    • T.D. Reynolds, L. Buonocore, N.F. Rose, J.K. Rose, and M.D. Robek Virus-Like vesicle-based therapeutic vaccine vectors for chronic hepatitis B virus infection J. Virol. 2015
    • (2015) J. Virol.
    • Reynolds, T.D.1    Buonocore, L.2    Rose, N.F.3    Rose, J.K.4    Robek, M.D.5
  • 91
    • 0016206027 scopus 로고
    • DNA polymerase in the core of the human hepatitis B virus candidate
    • W.S. Robinson, and R.L. Greenman DNA polymerase in the core of the human hepatitis B virus candidate J. Virol. 6 1974 1231 1236
    • (1974) J. Virol. , vol.6 , pp. 1231-1236
    • Robinson, W.S.1    Greenman, R.L.2
  • 93
    • 77955430666 scopus 로고    scopus 로고
    • The woodchuck: A model for therapeutic vaccination against hepadnaviral infection
    • M. Roggendorf, D. Yang, and M. Lu The woodchuck: a model for therapeutic vaccination against hepadnaviral infection Pathol. Biol. (Paris) 4 2010 308 314
    • (2010) Pathol. Biol. (Paris) , vol.4 , pp. 308-314
    • Roggendorf, M.1    Yang, D.2    Lu, M.3
  • 94
    • 0030959049 scopus 로고    scopus 로고
    • Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B
    • S. Rossol, G. Marinos, P. Carucci, M.V. Singer, R. Williams, and N.V. Naoumov Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B J. Clin. Invest. 12 1997 3025 3033
    • (1997) J. Clin. Invest. , vol.12 , pp. 3025-3033
    • Rossol, S.1    Marinos, G.2    Carucci, P.3    Singer, M.V.4    Williams, R.5    Naoumov, N.V.6
  • 97
    • 0025183686 scopus 로고
    • Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts
    • M. Seifer, K.H. Heermann, and W.H. Gerlich Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts Virology 1 1990 287 299
    • (1990) Virology , vol.1 , pp. 287-299
    • Seifer, M.1    Heermann, K.H.2    Gerlich, W.H.3
  • 99
    • 84916219853 scopus 로고    scopus 로고
    • Lymphotoxin beta receptor activation promotes bladder cancer in a nuclear factor-kappaB-dependent manner
    • M. Shen, X. Duan, P. Zhou, W. Zhou, X. Wu, S. Xu, Y. Chen, and Z. Tao Lymphotoxin beta receptor activation promotes bladder cancer in a nuclear factor-kappaB-dependent manner Mol. Med. Rep. 2 2015 783 790
    • (2015) Mol. Med. Rep. , vol.2 , pp. 783-790
    • Shen, M.1    Duan, X.2    Zhou, P.3    Zhou, W.4    Wu, X.5    Xu, S.6    Chen, Y.7    Tao, Z.8
  • 100
    • 84922362557 scopus 로고    scopus 로고
    • Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B
    • M. Shi, W.L. Sun, Y.Y. Hua, B. Han, and L. Shi Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B PLoS One 2 2015 e117741
    • (2015) PLoS One , vol.2 , pp. e117741
    • Shi, M.1    Sun, W.L.2    Hua, Y.Y.3    Han, B.4    Shi, L.5
  • 101
    • 84902967486 scopus 로고    scopus 로고
    • Opening fronts in HIV vaccine development: Targeting reservoirs to clear and cure
    • R.F. Siliciano Opening fronts in HIV vaccine development: targeting reservoirs to clear and cure Nat. Med. 5 2014 480 481
    • (2014) Nat. Med. , vol.5 , pp. 480-481
    • Siliciano, R.F.1
  • 102
    • 84903615913 scopus 로고    scopus 로고
    • Recent developments in the search for a cure for HIV-1 infection: Targeting the latent reservoir for HIV-1
    • J.D. Siliciano, and R.F. Siliciano Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1 J. Allergy Clin. Immunol. 1 2014 12 19
    • (2014) J. Allergy Clin. Immunol. , vol.1 , pp. 12-19
    • Siliciano, J.D.1    Siliciano, R.F.2
  • 103
    • 84943383941 scopus 로고    scopus 로고
    • Natural killer cell characteristics in patients with chronic hepatitis B virus (HBV) infection are associated with HBV surface antigen clearance after combination treatment with pegylated interferon alfa-2a and adefovir
    • F. Stelma, A. de Niet, P.M. Tempelmans, L. Jansen, R.B. Takkenberg, H.W. Reesink, N.A. Kootstra, and E.M. van Leeuwen Natural killer cell characteristics in patients with chronic hepatitis B virus (HBV) infection are associated with HBV surface antigen clearance after combination treatment with pegylated interferon alfa-2a and adefovir J. Infect. Dis. 2015
    • (2015) J. Infect. Dis.
    • Stelma, F.1    De Niet, A.2    Tempelmans, P.M.3    Jansen, L.4    Takkenberg, R.B.5    Reesink, H.W.6    Kootstra, N.A.7    Van Leeuwen, E.M.8
  • 104
    • 0020526688 scopus 로고
    • Structural relationships between minor and major proteins of hepatitis B surface antigen
    • W. Stibbe, and W.H. Gerlich Structural relationships between minor and major proteins of hepatitis B surface antigen J. Virol. 2 1983 626 628
    • (1983) J. Virol. , vol.2 , pp. 626-628
    • Stibbe, W.1    Gerlich, W.H.2
  • 105
    • 33845868485 scopus 로고    scopus 로고
    • BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly
    • S.J. Stray, and A. Zlotnick BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly J. Mol. Recognit. 6 2006 542 548
    • (2006) J. Mol. Recognit. , vol.6 , pp. 542-548
    • Stray, S.J.1    Zlotnick, A.2
  • 106
    • 84937072813 scopus 로고    scopus 로고
    • Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B
    • F. Su, J. Dai, S. Yang, X. Jiang, X. Cui, H. Ning, J. Li, and M. Huang Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B J. Med. Virol. 9 2015 1527 1531
    • (2015) J. Med. Virol. , vol.9 , pp. 1527-1531
    • Su, F.1    Dai, J.2    Yang, S.3    Jiang, X.4    Cui, X.5    Ning, H.6    Li, J.7    Huang, M.8
  • 107
    • 0019949367 scopus 로고
    • Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate
    • J. Summers, and W.S. Mason Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate Cell 2 1982 403 415
    • (1982) Cell , vol.2 , pp. 403-415
    • Summers, J.1    Mason, W.S.2
  • 108
    • 84928887199 scopus 로고    scopus 로고
    • NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
    • C. Sun, H. Sun, C. Zhang, and Z. Tian NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma Cell Mol. Immunol. 3 2015 292 302
    • (2015) Cell Mol. Immunol. , vol.3 , pp. 292-302
    • Sun, C.1    Sun, H.2    Zhang, C.3    Tian, Z.4
  • 110
    • 15244343352 scopus 로고    scopus 로고
    • Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection
    • A. Szkaradkiewicz, A. Jopek, and J. Wysocki Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection Antiviral Res. 1 2005 23 27
    • (2005) Antiviral Res. , vol.1 , pp. 23-27
    • Szkaradkiewicz, A.1    Jopek, A.2    Wysocki, J.3
  • 111
    • 84889803644 scopus 로고    scopus 로고
    • A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity
    • W. Tan, Y. Meng, H. Li, Y. Chen, S. Han, J. Zeng, A. Huang, B. Li, Y. Zhang, and Y. Guo A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity mAbs-Austin 6 2013 946 955
    • (2013) MAbs-Austin , vol.6 , pp. 946-955
    • Tan, W.1    Meng, Y.2    Li, H.3    Chen, Y.4    Han, S.5    Zeng, J.6    Huang, A.7    Li, B.8    Zhang, Y.9    Guo, Y.10
  • 112
    • 84927950089 scopus 로고    scopus 로고
    • The hepatitis B virus ribonuclease H as a drug target
    • J.E. Tavis, and E. Lomonosova The hepatitis B virus ribonuclease H as a drug target Antiviral Res. 2015 132 138
    • (2015) Antiviral Res. , pp. 132-138
    • Tavis, J.E.1    Lomonosova, E.2
  • 113
    • 84893716133 scopus 로고    scopus 로고
    • Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B
    • E.T. Tjwa, R. Zoutendijk, G.W. van Oord, P.J. Biesta, J. Verheij, H.L. Janssen, A.M. Woltman, and A. Boonstra Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B Liver Int. 3 2014 396 404
    • (2014) Liver Int. , vol.3 , pp. 396-404
    • Tjwa, E.T.1    Zoutendijk, R.2    Van Oord, G.W.3    Biesta, P.J.4    Verheij, J.5    Janssen, H.L.6    Woltman, A.M.7    Boonstra, A.8
  • 114
    • 84983720423 scopus 로고    scopus 로고
    • PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
    • H.T. Tzeng, H.F. Tsai, H.J. Liao, Y.J. Lin, L. Chen, P.J. Chen, and P.N. Hsu PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model PLoS One 6 2012 e39179
    • (2012) PLoS One , vol.6 , pp. e39179
    • Tzeng, H.T.1    Tsai, H.F.2    Liao, H.J.3    Lin, Y.J.4    Chen, L.5    Chen, P.J.6    Hsu, P.N.7
  • 116
    • 84930209100 scopus 로고    scopus 로고
    • Delayed reduction of hepatitis B viral load and dynamics of adefovir-resistant variants during adefovir plus entecavir combination rescue therapy
    • Y. Wang, S. Liu, Y. Chen, S. Zheng, L. Zhou, F. Lu, and Z. Duan Delayed reduction of hepatitis B viral load and dynamics of adefovir-resistant variants during adefovir plus entecavir combination rescue therapy Int. J. Med. Sci. 5 2015 416 422
    • (2015) Int. J. Med. Sci. , vol.5 , pp. 416-422
    • Wang, Y.1    Liu, S.2    Chen, Y.3    Zheng, S.4    Zhou, L.5    Lu, F.6    Duan, Z.7
  • 118
    • 84880608443 scopus 로고    scopus 로고
    • Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency
    • D.K. Wong, W.K. Seto, J. Fung, P. Ip, F.Y. Huang, C.L. Lai, and M.F. Yuen Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency Clin. Gastroenterol. Hepatol. 8 2013 1004 1010
    • (2013) Clin. Gastroenterol. Hepatol. , vol.8 , pp. 1004-1010
    • Wong, D.K.1    Seto, W.K.2    Fung, J.3    Ip, P.4    Huang, F.Y.5    Lai, C.L.6    Yuen, M.F.7
  • 119
    • 72249119029 scopus 로고    scopus 로고
    • Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion
    • J.F. Wu, T.C. Wu, C.H. Chen, Y.H. Ni, H.L. Chen, H.Y. Hsu, and M.H. Chang Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion Gastroenterology 1 2010 165 172
    • (2010) Gastroenterology , vol.1 , pp. 165-172
    • Wu, J.F.1    Wu, T.C.2    Chen, C.H.3    Ni, Y.H.4    Chen, H.L.5    Hsu, H.Y.6    Chang, M.H.7
  • 120
    • 84860347302 scopus 로고    scopus 로고
    • Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B
    • W. Wu, Y. Shi, S. Li, Y. Zhang, Y. Liu, Y. Wu, and Z. Chen Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B Eur. J. Immunol. 5 2012 1180 1191
    • (2012) Eur. J. Immunol. , vol.5 , pp. 1180-1191
    • Wu, W.1    Shi, Y.2    Li, S.3    Zhang, Y.4    Liu, Y.5    Wu, Y.6    Chen, Z.7
  • 123
    • 84938204671 scopus 로고    scopus 로고
    • Natural killer cells in hepatitis B virus infection
    • S.F. Wu, W.J. Wang, and Y.Q. Gao Natural killer cells in hepatitis B virus infection Braz. J. Infect. Dis. 4 2015 417 425
    • (2015) Braz. J. Infect. Dis. , vol.4 , pp. 417-425
    • Wu, S.F.1    Wang, W.J.2    Gao, Y.Q.3
  • 124
    • 33947397924 scopus 로고    scopus 로고
    • IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers
    • S.Q. Xiong, B.L. Lin, X. Gao, H. Tang, and C.Y. Wu IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers Int. Immunopharmacol. 5 2007 578 587
    • (2007) Int. Immunopharmacol. , vol.5 , pp. 578-587
    • Xiong, S.Q.1    Lin, B.L.2    Gao, X.3    Tang, H.4    Wu, C.Y.5
  • 127
    • 84896934689 scopus 로고    scopus 로고
    • The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics
    • P. Xu, Y.J. Chen, H. Chen, X.Y. Zhu, H.F. Song, L.J. Cao, and X.F. Wang The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics Gut Liver 2 2014 186 195
    • (2014) Gut Liver , vol.2 , pp. 186-195
    • Xu, P.1    Chen, Y.J.2    Chen, H.3    Zhu, X.Y.4    Song, H.F.5    Cao, L.J.6    Wang, X.F.7
  • 129
    • 84940515778 scopus 로고    scopus 로고
    • The Interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion
    • R. Yan, X. Zhao, D. Cai, Y. Liu, T.M. Block, J.T. Guo, and H. Guo The Interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion J. Virol. 18 2015 9200 9212
    • (2015) J. Virol. , vol.18 , pp. 9200-9212
    • Yan, R.1    Zhao, X.2    Cai, D.3    Liu, Y.4    Block, T.M.5    Guo, J.T.6    Guo, H.7
  • 130
    • 33846650945 scopus 로고    scopus 로고
    • Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients
    • X. Yao, B. Zheng, J. Zhou, D.Z. Xu, K. Zhao, S.H. Sun, Z.H. Yuan, and Y.M. Wen Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients Vaccine 10 2007 1771 1779
    • (2007) Vaccine , vol.10 , pp. 1771-1779
    • Yao, X.1    Zheng, B.2    Zhou, J.3    Xu, D.Z.4    Zhao, K.5    Sun, S.H.6    Yuan, Z.H.7    Wen, Y.M.8
  • 131
    • 80051865054 scopus 로고    scopus 로고
    • Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion
    • W. Yu, C. Goddard, E. Clearfield, C. Mills, T. Xiao, H. Guo, J.D. Morrey, N.E. Motter, K. Zhao, T.M. Block, A. Cuconati, and X. Xu Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion J. Med. Chem. 16 2011 5660 5670
    • (2011) J. Med. Chem. , vol.16 , pp. 5660-5670
    • Yu, W.1    Goddard, C.2    Clearfield, E.3    Mills, C.4    Xiao, T.5    Guo, H.6    Morrey, J.D.7    Motter, N.E.8    Zhao, K.9    Block, T.M.10    Cuconati, A.11    Xu, X.12
  • 132
    • 84885445313 scopus 로고    scopus 로고
    • IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier
    • Z. Zeng, X. Kong, F. Li, H. Wei, R. Sun, and Z. Tian IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier J. Immunol. 8 2013 4184 4193
    • (2013) J. Immunol. , vol.8 , pp. 4184-4193
    • Zeng, Z.1    Kong, X.2    Li, F.3    Wei, H.4    Sun, R.5    Tian, Z.6
  • 133
    • 84921967768 scopus 로고    scopus 로고
    • Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection
    • E. Zhang, and M. Lu Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection Med. Microbiol. Immunol. 1 2015 11 20
    • (2015) Med. Microbiol. Immunol. , vol.1 , pp. 11-20
    • Zhang, E.1    Lu, M.2
  • 134
    • 80054095779 scopus 로고    scopus 로고
    • The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection
    • E. Zhang, X. Zhang, J. Liu, B. Wang, Y. Tian, A.D. Kosinska, Z. Ma, Y. Xu, U. Dittmer, M. Roggendorf, D. Yang, and M. Lu The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection PLoS One 10 2011 e26196
    • (2011) PLoS One , vol.10 , pp. e26196
    • Zhang, E.1    Zhang, X.2    Liu, J.3    Wang, B.4    Tian, Y.5    Kosinska, A.D.6    Ma, Z.7    Xu, Y.8    Dittmer, U.9    Roggendorf, M.10    Yang, D.11    Lu, M.12
  • 135
    • 84886502709 scopus 로고    scopus 로고
    • Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B
    • W.J. Zhang, C.H. Peng, and S.S. Zheng Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B Hepatobiliary Pancreat. Dis. Int. 4 2013 394 399
    • (2013) Hepatobiliary Pancreat. Dis. Int. , vol.4 , pp. 394-399
    • Zhang, W.J.1    Peng, C.H.2    Zheng, S.S.3
  • 136
    • 84911374800 scopus 로고    scopus 로고
    • Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss
    • Q. Zheng, Y.Y. Zhu, J. Chen, Y.R. Liu, J. You, J. Dong, D.W. Zeng, L.Y. Gao, L.H. Chen, and J.J. Jiang Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss J. Viral Hepat. 12 2014 909 916
    • (2014) J. Viral Hepat. , vol.12 , pp. 909-916
    • Zheng, Q.1    Zhu, Y.Y.2    Chen, J.3    Liu, Y.R.4    You, J.5    Dong, J.6    Zeng, D.W.7    Gao, L.Y.8    Chen, L.H.9    Jiang, J.J.10
  • 137
  • 138
    • 84923769732 scopus 로고    scopus 로고
    • Antiviral therapies and prospects for a cure of chronic hepatitis B
    • F. Zoulim, and D. Durantel Antiviral therapies and prospects for a cure of chronic hepatitis B Cold Spring Harb. Perspect. Med. 2015 4
    • (2015) Cold Spring Harb. Perspect. Med. , pp. 4
    • Zoulim, F.1    Durantel, D.2
  • 139
    • 70350095437 scopus 로고    scopus 로고
    • Hepatitis B virus resistance to nucleos(t)ide analogues
    • F. Zoulim, and S. Locarnini Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 5 2009 1593 1608
    • (2009) Gastroenterology , vol.5 , pp. 1593-1608
    • Zoulim, F.1    Locarnini, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.